IDO1 and primary cutaneous T-cell non-Hodgkin lymphoma: They also expressed IDO1 (Figure 5L), coding for the enzyme indoleamine-pyrrole 2,3-dioxygenase that has immunosuppressive and T-cell modulatory functions, potentially involved in CTCL pathogenesis (48).